Pancreatic Cancer Research

ResearcherSemmelweis UniversityActive in the last 2 years

Sebastian Krug

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1672-7995; OpenAlex author ID A5062126812. Sources: OpenAlex.

Their work

Papers
15 (first author 1, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
42
Papers, trials and grants by year

2012: 1 paper · 2013: 2 papers · 2014: none · 2015: 1 paper · 2016: 3 papers · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: none · 2023: 2 papers · 2024: none · 2025: 2 papers

Papers 15

  1. Trends in the Treatment and Survival of Pancreatic Cancer: Analysis of 23,339 Patients Diagnosed Between 2010 and 2017. Last author DOI 10.1002/cam4.71248↗
  2. Innate Immunity and Platelets: Unveiling Their Role in Chronic Pancreatitis and Pancreatic Cancer. Co-author DOI 10.3390/cancers17101689↗
  3. Body composition parameters predict survival in pancreatic cancer-A retrospective multicenter analysis. Co-author DOI 10.1002/ueg2.12489↗
  4. Gender-specific changes of the gut microbiome correlate with tumor development in murine models of pancreatic cancer. Co-author DOI 10.1016/j.isci.2023.106841↗
  5. Pre-operative/Neoadjuvant Therapy and Vascular Debranching Followed by Resection for Locally Advanced Pancreatic Cancer (PREVADER): Clinical Feasibility Trial. Co-author DOI 10.3389/fmed.2021.588375↗
  6. Efficacy and Safety of Neoadjuvant Gemcitabine Plus Nab-Paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Cancer-A Systematic Review and Meta… Last author DOI 10.3390/cancers13174326↗
  7. Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe. Last author DOI 10.1016/j.pan.2018.10.003↗
  8. Overcoming immune evasion in pancreatic cancer: the combination matters. First author DOI 10.1136/gutjnl-2017-315443↗
  9. Prognostic and predictive markers in pancreatic adenocarcinoma. Co-author DOI 10.1016/j.dld.2015.11.001↗
  10. miRNA dynamics in tumor-infiltrating myeloid cells modulating tumor progression in pancreatic cancer. Co-author DOI 10.1080/2162402x.2016.1160181↗
  11. Real-World Clinical Practice of Intensified Chemotherapies for Metastatic Pancreatic Cancer: Results from a Pan-European Questionnaire Study. Co-author DOI 10.1159/000453257↗
  12. New Advances in the Treatment of Metastatic Pancreatic Cancer. Last author DOI 10.1159/000439523↗
  13. Synthetic lethality screen identifies RPS6KA2 as modifier of epidermal growth factor receptor activity in pancreatic cancer. Co-author DOI 10.1593/neo.131660↗
  14. Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma. Last author DOI 10.2147/ott.s38111↗
  15. New developments in pancreatic cancer treatment. Co-author PMID 23207616↗

Closest collaborators

The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Patrick Michl · 9 shared papers, 2013–2025 · strength 1.23
  2. Jonas Rosendahl · 4 shared papers, 2021–2025 · strength 0.77
  3. Marko Damm · 3 shared papers, 2021–2025 · strength 0.61
  4. Monika Hämmerle · 2 shared papers, 2023–2025 · strength 0.41
  5. Marvin Schober · 5 shared papers, 2015–2019 · strength 0.30
  6. Jorg H. Kleeff · 2 shared papers, 2021 · strength 0.29
  7. Heidi Griesmann · 3 shared papers, 2013–2023 · strength 0.25
  8. Nha Ngoc Hoa Le · 4 shared papers, 2015–2019 · strength 0.25
  9. Malin Sund · 4 shared papers, 2015–2019 · strength 0.25
  10. Juliane Blümke · 1 shared paper, 2025 · strength 0.25
  11. Ivonne Bazwinsky‐Wutschke · 1 shared paper, 2025 · strength 0.25
  12. Elise Arlt · 1 shared paper, 2025 · strength 0.25
  13. Sonja M. Kessler · 1 shared paper, 2025 · strength 0.25
  14. Albrecht Neeße · 4 shared papers, 2013–2019 · strength 0.23
  15. Muhammad Ahsan Javed · 3 shared papers, 2015–2019 · strength 0.18
  16. Georg Beyer · 3 shared papers, 2015–2019 · strength 0.18
  17. Andrew Derek Hopper · 1 shared paper, 2023 · strength 0.17
  18. Mustafa Jalal · 1 shared paper, 2023 · strength 0.17
  19. Tom Kaune · 1 shared paper, 2023 · strength 0.16
  20. Ulrich Ronellenfitsch · 1 shared paper, 2021 · strength 0.16
  21. Christoph W. Michalski · 1 shared paper, 2021 · strength 0.16
  22. Thomas Mathias Gress · 3 shared papers, 2013–2016 · strength 0.13
  23. Gretel Terrero · 1 shared paper, 2021 · strength 0.13
  24. Leonie Mühlberg · 2 shared papers, 2013–2016 · strength 0.09
  25. Salma Moona Alam · 1 shared paper, 2019 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.